AIT gains FDA nod for imaging/biopsy system:
This article was originally published in Clinica
Executive Summary
Advanced Imaging Technologies (AIT) has gained US FDA 510(k) clearance for a breast biopsy capability on its Avera breast imaging system. The new indication will allow physicians to perform immediate biopsies on suspicious breast masses during an Avera imaging session, as the patient does not have to move from their position, says the Preston, Washington firm. Additionally, the biopsy procedure can be performed sooner; sometimes the period between mass detection and biopsy can be several days, says AIT.